Hanspeter Gerber, PhD

CEO and CSO

Management Team

  • 20+ years of industry experience
  • Oversaw 10+ IND & BLA filings (Avastin, Bespona, Mylotarg)
  • Former CSO, Oncology Research Unit, Pfizer (+100 FTEs, Initiated R&D collaborations Stemcentrx, Cytomx, MacroGenics)
  • Oversaw development of ADC, Bi-specific and conditional platforms

Management Team

Scientific Advisory Board

Contributors